Inauguration of Biological and Peptide Products and Vaccine Production Lines at Biosun Pharmed on July 6, 2022.
Biosun Pharmed has consistently strived to take significant steps toward enhancing the quality of life and health of our fellow citizens. In alignment with the general policies of the Resistance Economy, the company focuses on developing domestic production of high-tech and knowledge-based pharmaceutical products by utilizing national infrastructure and the expertise of young Iranian specialists to foster job creation and national independence.
By the grace of the Almighty and supported by the dedication and knowledge of the youth of Islamic Iran, the production lines for biological and peptide products, as well as modern vaccines—including the HPV (Human Papillomavirus) cervical cancer vaccine—were officially inaugurated on July 6, 2022 (15 Tir 1401), within the Barekat Pharmaceutical Group complex.
While the core technical knowledge for producing biologicals, peptides, and vaccines is predominantly held by foreign countries, Biosun Pharmed, as a knowledge-based company, has succeeded in developing the technical expertise for these products. By relying on advanced manufacturing infrastructure and the knowledge of internal researchers, the company now stands on par with leading global pharmaceutical firms.
The products manufactured on these lines are utilized in the prevention and treatment of cancer, cardiovascular diseases, Multiple Sclerosis (MS), infertility, and hematological (blood) disorders.
